Patheon Pharmaceuticals Inc. c/o Thermo Fisher Scientific
Patheon is a leading global provider of contract dosage form development and manufacturing services to the pharmaceutical and biotechnology industries.
Employing more than 4,000 highly-skilled staff, Patheon?s network of modern manufacturing facilities located in North America and Europe offer more than three million square feet (300,000 m2) of best in class capacity. With three facilities in the United States, three in Canada and four in Europe (including two in Italy, one in France and one in the United Kingdom) Patheon is able to meet the international requirements of its customers.
Patheon?s development and manufacturing capabilities cover prescription (Rx) products in solid, semi-solid and liquid dosage forms, as well as specialized capabilities in high-potency, cephalosporin, controlled/sustained release and sterile manufacturing, including aseptic filling and lyophilization.
Our Pharmaceutical Development Services (PDS) group offers contract pre-formulation, formulation and analytical development, clinical trial materials (CTM) manufacturing, clinical packaging and scale-up services for pharmaceutical products of essentially all types, including biopharmaceuticals.
Founded in 1974 and publicly traded since 1993 (TSX: PTI) Patheon has always been exclusively focused on outsourcing. Patheon proudly serves more than 300 customers including many of the world?s leading pharmaceutical, biotechnology and specialty pharmaceutical companies.
We provide fully integrated contract manufacturing and development solutions to our customers, from early development through to high-volume commercial manufacturing and packaging. Offering world-class facilities and expertise, and an unwavering focus on service quality, Patheon is uniquely positioned to serve as the pharmaceutic